Cargando…

Fragment-based drug discovery: opportunities for organic synthesis

This Review describes the increasing demand for organic synthesis to facilitate fragment-based drug discovery (FBDD), focusing on polar, unprotected fragments. In FBDD, X-ray crystal structures are used to design target molecules for synthesis with new groups added onto a fragment via specific growt...

Descripción completa

Detalles Bibliográficos
Autores principales:	St. Denis, Jeffrey D., Hall, Richard J., Murray, Christopher W., Heightman, Tom D., Rees, David C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	RSC 2020
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130625/ https://www.ncbi.nlm.nih.gov/pubmed/34041484 http://dx.doi.org/10.1039/d0md00375a

Ejemplares similares

Enabling synthesis in fragment-based drug discovery by reactivity mapping: photoredox-mediated cross-dehydrogenative heteroarylation of cyclic amines
por: Grainger, Rachel, et al.
Publicado: (2018)

C–H functionalisation tolerant to polar groups could transform fragment-based drug discovery (FBDD)
por: Chessari, Gianni, et al.
Publicado: (2021)

Is it time for biocatalysis in fragment-based drug discovery?
por: Ramsden, Jeremy I., et al.
Publicado: (2020)

In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
por: de Souza Neto, Lauro Ribeiro, et al.
Publicado: (2020)

Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development
por: Staśkiewicz, Agnieszka, et al.
Publicado: (2021)

PAC-FragmentDEL – photoactivated covalent capture of DNA-encoded fragments for hit discovery
por: Ma, Huiyong, et al.
Publicado: (2022)

Fragment-based covalent ligand discovery
por: Lu, Wenchao, et al.
Publicado: (2021)

Editorial: Advances in green synthesis for drug discovery
por: Allais, Florent, et al.
Publicado: (2023)

Embracing the Diversity of Halogen Bonding Motifs in Fragment-Based Drug Discovery—Construction of a Diversity-Optimized Halogen-Enriched Fragment Library
por: Heidrich, Johannes, et al.
Publicado: (2019)

Correction: Fragment-based covalent ligand discovery
por: Lu, Wenchao, et al.
Publicado: (2021)

Fragment optimization and elaboration strategies – the discovery of two lead series of PRMT5/MTA inhibitors from five fragment hits
por: Smith, Christopher R., et al.
Publicado: (2022)

Metallodrugs are unique: opportunities and challenges of discovery and development
por: Anthony, Elizabeth J., et al.
Publicado: (2020)

Discovery of a novel kinase hinge binder fragment by dynamic undocking
por: Rachman, Moira, et al.
Publicado: (2020)

Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery
por: Morrison, Christine N., et al.
Publicado: (2019)

Natural products in drug discovery and development: Synthesis and medicinal perspective of leonurine
por: Li, Zhaoyi, et al.
Publicado: (2022)

Correction: Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery
por: Morrison, Christine N., et al.
Publicado: (2022)

Fragment synthesis of disulfide-containing peptides
por: Dai, Yuxuan, et al.
Publicado: (2020)

Cycloaddition Strategies for the Synthesis of Diverse Heterocyclic Spirocycles for Fragment‐Based Drug Discovery
por: King, Thomas A., et al.
Publicado: (2019)

Further correction: Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery
por: Morrison, Christine N., et al.
Publicado: (2023)

Arylnaphthalene lactone analogues: synthesis and development as excellent biological candidates for future drug discovery
por: Zhao, Chuang, et al.
Publicado: (2018)

Glycans in drug discovery
por: Valverde, Pablo, et al.
Publicado: (2019)

Mycobacterial drug discovery
por: Abrahams, Katherine A., et al.
Publicado: (2020)

Current challenges in peptide-based drug discovery
por: Otvos, Laszlo, et al.
Publicado: (2014)

Fragments and hot spots in drug discovery
por: Vajda, Sandor, et al.
Publicado: (2015)

An Update on CFTR Drug Discovery: Opportunities and Challenges
por: D’Ursi, Pasqualina, et al.
Publicado: (2022)

Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
por: McAulay, Kirsten, et al.
Publicado: (2022)

Modification of Oligo- and Polylactides With Macrocyclic Fragments: Synthesis and Properties
por: Mostovaya, Olga A., et al.
Publicado: (2019)

Suzuki coupling-based synthesis of VATPase inhibitor archazolid natural product derived fragments
por: Vincent, Cooper T., et al.
Publicado: (2019)

Deuterium in drug discovery: progress, opportunities and challenges
por: Di Martino, Rita Maria Concetta, et al.
Publicado: (2023)

Challenges and opportunities for chiral covalent organic frameworks
por: Kang, Xing, et al.
Publicado: (2022)

Discovery of 2-phenoxyacetamides as inhibitors of the Wnt-depalmitoleating enzyme NOTUM from an X-ray fragment screen
por: Atkinson, Benjamin N., et al.
Publicado: (2019)

Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
por: Konaklieva, Monika I., et al.
Publicado: (2023)

DNA display of fragment pairs as a tool for the discovery of novel biologically active small molecules
por: Daguer, J.-P., et al.
Publicado: (2015)

Design and characterization of a heterocyclic electrophilic fragment library for the discovery of cysteine-targeted covalent inhibitors
por: Keeley, A., et al.
Publicado: (2018)

Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe
por: Lebraud, Honorine, et al.
Publicado: (2018)

A fragment-based approach leading to the discovery of inhibitors of CK2α with a novel mechanism of action
por: Brear, Paul, et al.
Publicado: (2022)

Correction: Suzuki coupling-based synthesis of VATPase inhibitor archazolid natural product derived fragments
por: Vincent, Cooper A., et al.
Publicado: (2019)

Exploration of piperidine 3D fragment chemical space: synthesis and 3D shape analysis of fragments derived from 20 regio- and diastereoisomers of methyl substituted pipecolinates
por: Jones, S. Paul, et al.
Publicado: (2022)

(19)F NMR viewed through two different lenses: ligand-observed and protein-observed (19)F NMR applications for fragment-based drug discovery
por: Buchholz, Caroline R., et al.
Publicado: (2021)

Natural product drug discovery in the artificial intelligence era
por: Saldívar-González, F. I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_63u0cmd1u6stpknjs5def9lfba